Literature DB >> 18245515

Pseudoprogression of lung cancer after concomitant chemoradiotherapy.

Eiki Ichihara1, Katsuyuki Kiura, Nagio Takigawa, Masako Omori, Motoi Aoe, Mitsune Tanimoto, Hiroshi Date.   

Abstract

We observed re-enlargement of a squamous cell carcinoma without recurrence. The tumour regressed markedly after concomitant chemoradiotherapy, but within 1 month, we supposed that the tumour had enlarged again and resection was performed. The resected tissue showed evidence of haemorrhage and several lymphocytes and macrophages, but no malignant cells were detected. We herein report a rare case of lung cancer showing a pathological complete response despite re-enlargement of tumour lesion.

Entities:  

Mesh:

Year:  2008        PMID: 18245515     DOI: 10.1093/jjco/hym166

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.

Authors:  Michael Iv; Peyman Samghabadi; Samantha Holdsworth; Andrew Gentles; Paymon Rezaii; Griffith Harsh; Gordon Li; Reena Thomas; Michael Moseley; Heike E Daldrup-Link; Hannes Vogel; Max Wintermark; Samuel Cheshier; Kristen W Yeom
Journal:  Radiology       Date:  2018-11-06       Impact factor: 11.105

2.  Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status.

Authors:  D-S Kong; S T Kim; E-H Kim; D H Lim; W S Kim; Y-L Suh; J-I Lee; K Park; J H Kim; D-H Nam
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-20       Impact factor: 3.825

Review 3.  Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients.

Authors:  Roh-Eul Yoo; Seung Hong Choi
Journal:  Magn Reson Med Sci       Date:  2015-12-28       Impact factor: 2.471

4.  QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.

Authors:  Yaqi Li; Mei Liu; Zhuoxian Zhang; Libin Deng; ZhenYu Zhai; Hua Liu; Yiting Wang; Cheng Zhang; Jianping Xiong; Chao Shi
Journal:  Front Cell Dev Biol       Date:  2021-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.